Rising burden of gallbladder and biliary tract cancer
Although cancers that occur in the gallbladder or bile ducts are rare, their rates are increasing. A recent study provides details on the burden of gallbladder and biliary… read more.
Although cancers that occur in the gallbladder or bile ducts are rare, their rates are increasing. A recent study provides details on the burden of gallbladder and biliary… read more.
Interview and article by Christine Clark. The real world evidence about ivermectin combined with the findings from meta-analyses of clinical trials provide compelling evidence for the safety and… read more.
AbbVie announced that the FDA has extended the review period for the supplemental New Drug Application (sNDA) for upadacitinib in the treatment of adult patients with active psoriatic… read more.
Cancers are not only made of tumour cells. In fact, as they grow, they develop an entire cellular ecosystem within and around them. This “tumour microenvironment” is made… read more.
Interview and article by Christine Clark. The results of the recent controlled trial of ivermectin for covid-19 in Colombia suggest that both ivermectin and control groups received ivermectin,… read more.
Interview and article by Christine Clark Dr David Scheim explains how multiple protocol violations and widespread use of over-the-counter ivermectin could have compromised the results of a recent… read more.
The Israel Ministry of Health (MoH), Pfizer Inc. and BioNTech SE announced real-world evidence demonstrating dramatically lower incidence rates of COVID-19 disease in individuals fully vaccinated with the… read more.
Interview and article by Christine Clark Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as… read more.
Interview and article by Christine Clark Further analysis of results from Peru has now shown that systematic treatment of the population for covid-19 with ivermectin resulted in a… read more.
The Medicines Health Regulatory Authority (MHRA) and European Medicines Agency (EMA) reaffirmed the benefits of COVID-19 Vaccine AstraZeneca continue to far outweigh the risks.
Allarity Therapeutics A/S announced that it has enrolled the first patient in its European Phase II clinical trial of Ixempra (ixabepilone) for the treatment of metastatic breast cancer.
Research from Queen Mary University of London has concluded that there is convincing evidence that type 2 diabetes is associated with an increased risk of Parkinson’s disease. The… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.